DexCom (DXCM) Tops Q4 EPS by 7c

DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $815.2 million versus the consensus estimate of $809.35 million.

GUIDANCE:

DexCom sees Q1 2023 revenue of $3.35-3.49 billion, versus the consensus of $3.47 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Middleby completes spin-off of food processing unit as Midera
• Solstice to acquire Element Solutions in $14.5B deal